Filing metadata

Accession number
0001567619-21-017624
Form type
Form 4
Filer
4D Molecular Therapeutics, Inc.
CIK
CIK 1650648
Filed
Sep 29, 2021
Reporting period
Sep 27, 2021
Description
Insider transaction

Explore SEC Filings Hub